PSA/fPSA immunoassay analysis

Monday, 01 December, 2008 | Supplied by: Olympus Australia Pty Ltd


Olympus has released PSA and fPSA assays for the Olympus AU3000i immunoassay analyser. The assays feature assay sensitivity of 0.015 µg/L. In the monitoring of patients after prostate cancer treatment, the sensitive PSA assay is suitable for the detection of recurrence of the disease.

The assays use a two-step immunometric design, minimising the risk of high-dose-hook and ensuring that the measurement of samples with elevated PSA levels will generate appropriate results. No high-dose-hook has been observed at PSA concentrations up to 160,000 µg/L, according to Olympus.

Other available test panels for the AU30001 include the primary tumour marker panel (AFP, CEA, PSA and fPSA) and the specialist tumour markers GI TN-TC and BR-TC.

 

Online: www.olympusaustralia.com.au
Phone: 03 9265 5400
Related Products

Hygiena foodproof Salmonella plus Cronobacter Detection LyoKit

Hygiena's foodproof Salmonella plus Cronobacter Detection LyoKit is an ISO...

Dojindo Laboratories ExoIsolator Exosome Isolation Kit

The ExoIsolator Exosome Isolation Kit, from Dojindo Laboratories, can collect exosomes...

Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research

Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd